Suppr超能文献

巴勒斯坦终末期肾病患者的骨矿物质密度及其相关临床和生化因素:横断面研究。

Bone mineral density in Palestinian patients with end-stage renal disease and the related clinical and biochemical factors: Cross-sectional study.

机构信息

Family and Community Medicine Department, Faculty of Medicine and Health Sciences, An-Najah National University, Nablus, Palestine.

Medicine Department, Faculty of Medicine and Health Sciences, An-Najah National University, Nablus, Palestine.

出版信息

PLoS One. 2020 Nov 12;15(11):e0241201. doi: 10.1371/journal.pone.0241201. eCollection 2020.

Abstract

INTRODUCTION

End-Stage Renal Disease (ESRD) is the ultimate result of chronic kidney disease (CKD). In Palestine, the prevalence of ESRD was 240.3 PMP which is comparable with the nearby countries. Accelerated bone loss among ESRD patients is attributed to abnormal bone turn over that leads to osteoporosis and osteopenia. The risk of fractures is increased four-fold in men and women on hemodialysis, which explains the importance of assessing the bone mineral density among these population. The goals of this study were to find the prevalence of osteoporosis in ESRD patients as determined by bone mineral density (BMD) at different sites and to determine whether BMD correlates with many other clinical parameters.

METHODS

A cross-sectional study of 194 ESRD patients were recruited from the dialysis unit in An-Najah National University Hospital, Nablus, Palestine. The patients were on regular hemodialysis or peritoneal dialysis. BMD was measured at the lumbar spine and the hip using the dual-energy X-Ray absorptiometry (DEXA) and the value is expressed as T-score. The data were analyzed using SPSS, version 26. The relationship between BMD and the clinical and biochemical parameters among the ESRD patients was assessed.

RESULTS

We found that 42.8% of ESRD patient had osteoporosis and 40.2% had osteopenia. There were significantly higher proportions of osteoporosis and osteopenia among patients >60 years of age (p<0.005). Patients with osteoporosis and osteopenia had significantly higher serum levels of PTH (792.9 and 469.7) (p<0.05). BMD decreases as the duration of dialysis (39.0 months Vs. 56.8 months), (p<0.05). We found no significant difference between patients on hemodialysis or peritoneal dialysis.

CONCLUSION

This study showed that Palestinian patients with ESRD have low BMD at the hip and spine. The observed high serum level of PTH was associated with low BMD. Those patients should be closely monitored especially those with more than one risk factor. Moreover, more attention should be paid for these category of patients to decrease the incidence of falling down and the resulting fractures that might lead to mortality and morbidity.

摘要

简介

终末期肾病(ESRD)是慢性肾脏病(CKD)的最终结果。在巴勒斯坦,ESRD 的患病率为 240.3 PMP,与附近国家相当。ESRD 患者的骨丢失加速归因于异常的骨转换,导致骨质疏松症和骨量减少。在接受血液透析的男性和女性中,骨折的风险增加了四倍,这解释了评估这些人群的骨矿物质密度的重要性。本研究的目的是确定不同部位骨矿物质密度(BMD)测定的 ESRD 患者骨质疏松症的患病率,并确定 BMD 是否与许多其他临床参数相关。

方法

对来自巴勒斯坦纳布卢斯纳贾赫国立大学医院透析科的 194 名 ESRD 患者进行横断面研究。患者正在接受常规血液透析或腹膜透析。使用双能 X 射线吸收法(DEXA)测量腰椎和髋关节的 BMD,并用 T 评分表示。使用 SPSS 版本 26 分析数据。评估 ESRD 患者的 BMD 与临床和生化参数之间的关系。

结果

我们发现 42.8%的 ESRD 患者患有骨质疏松症,40.2%的患者患有骨量减少。年龄>60 岁的患者中骨质疏松症和骨量减少的比例明显更高(p<0.005)。骨质疏松症和骨量减少患者的血清甲状旁腺激素(PTH)水平明显较高(792.9 和 469.7)(p<0.05)。BMD 随透析时间的延长而降低(39.0 个月 vs. 56.8 个月)(p<0.05)。我们未发现血液透析或腹膜透析患者之间存在显著差异。

结论

本研究表明,巴勒斯坦 ESRD 患者髋关节和脊柱的 BMD 较低。观察到的高血清甲状旁腺激素水平与低 BMD 相关。这些患者应密切监测,尤其是那些有一个以上危险因素的患者。此外,应更加关注这些类别的患者,以降低跌倒和由此导致的骨折的发生率,从而降低死亡率和发病率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9880/7661051/a3109a427c9c/pone.0241201.g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验